Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

Johnson and Johnson image

UPDATED: J&J in ‘game-changing’ data disclosure plan

January 30, 2014 Medical Communications, Research and Development, Sales and Marketing J&J, JJ, all trials, data, transparency, yoda

News
screen_shot_2014-02-04_at_14

Novo Nordisk appoints chief medical officer

January 30, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, todd hobbs

Dr Todd Hobbs has been appointed chief medical officer (CMO) for Novo Nordisk in North America.   In this role …
Appointment
screen_shot_2014-01-29_at_10

High-dose Copaxone the right medicine for Teva

January 29, 2014 Research and Development, Sales and Marketing Biogen, Copaxone, FDA, MS, Mylan, Teva

The FDA has approved a high-dose version of Teva’s multiple sclerosis drug Copaxone which will help the firm offset approaching …
News
matthias_zachert_merck

Merck KGaA head jumping ship to Lanxess

January 29, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck, Merck KGaA, lanxess, zachert

Merck KGaA’s chief financial officer Matthias Zachert is exiting the firm in order to fulfill a chief executive appointment at …
Appointment
servier image

Servier signs cancer partnership

January 29, 2014 Research and Development, Sales and Marketing AbbVie, Servier, breast cancer, curie

Servier has extended by three years its deal with leading research group Curie-Cancer to identify therapeutic targets for treating triple-negative …
News
Pfizer image

Pfizer lung cancer drug suffers late-stage setback

January 28, 2014 Research and Development, Sales and Marketing Cancer, NSCLC, Pfizer, Roche, Tarceva, dacomitinib

An experimental cancer drug developed by Pfizer has failed in two separate Phase III clinical studies. Dacomitinib is a tyrosine …
News
john_p

Targacept appoints chairman

January 28, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Targacept, richard

Clinical-stage biopharma firm Targecept has appointed its non-executive director since 2002 John Richard to be its chairman of the board. …
Appointment
nhs_parliament_2

NHS reform: did the government get it right?

January 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing DH, Hunt, Lansley, NHS, atkins, reform, reforms

Some nine months after the coalition government’s controversial health reforms came in, have they been a success? And how are …
Feature
robert_j

PTC Therapeutics makes series of changes

January 27, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing PTC Therapeutics

Biopharma firm PTC Therapeutics has expanded its senior management team with a raft of appointments. Robert Spiegel (pictured) becomes its …
Appointment
screen_shot_2014-01-23_at_08

Biotec Services appoints US head

January 23, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical trials services firm Biotec Services International is looking to expand its presence in the US with the appointment of …
Appointment

J&J tops social media leaderboard

January 22, 2014 Medical Communications, Research and Development, Sales and Marketing Facebook, IMS, J&J, JJ, Twitter, You Tube, social media

A new report has found that Johnson & Johnson is the most engaged pharma company when it comes to using …
News
screen_shot_2014-01-22_at_08

Director appointments at Hanover

January 22, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Hanover, harrison

Comms and PR consulting firm Hanover has announced senior management changes within its healthcare practice. Andrew Harrison (pictured) takes on …
Appointment
Biocon image

Herceptin biosimilar set for Indian market

January 21, 2014 Research and Development, Sales and Marketing Biocon, Herceptin, Roche, biosimilars, canmab

Biocon has said its generic version of Roche’s ageing breast cancer drug Herceptin will go on sale in India from …
News
Abbvie image

AbbVie advances oncology drug

January 21, 2014 Research and Development, Sales and Marketing AbbVie, DNA, oncology, veliparib

AbbVie has begun a Phase III trial of its investigational compound veliparib in women with early-stage, triple-negative breast cancer.  This …
News
Roche image

Roche schizophrenia drug fails

January 21, 2014 Research and Development, Sales and Marketing Roche, biopertin, schizophrenia

Roche’s investigational schizophrenia drug bitopertin has failed to help patients with the disorder’s negative symptoms when pitted against placebo. Two …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026